FindTrial
Sign In

Assessment of Pulmonary functions in patients receiving radiation therapy for lung cancer

"Comprehensive assessment of Pulmonary function in patients receiving radical Radiation Therapy for carcinoma lung (CoP-RT)" - CoP-RT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034156
Enrollment
200
Registered
2021-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C348- Malignant neoplasm of overlappingsites of bronchus and lung

Interventions

Intervention1: NIL: NIL

Sponsors

TATA MEMORIAL HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed cases of Ca Lung â?? SCLC or NSCLC. 2. Patient eligible/ suitable for radical or intent radical radiotherapy. 3. Age >18 years 4. Undergoing RT in TMH/ACTREC

Exclusion criteria

Exclusion criteria: 1. Receiving RT with palliative intent 2. Not willing to give consent 3. Thoracic Re-irradiation 4. Unable to perform to perform PFT/ DLCO

Design outcomes

Secondary

MeasureTime frame
CLINICORADIOLOGICAL CORRELATION, QUALITY OF LIFE, DOSIMETRIC FACTORSTimepoint: TWO YEARS—

Primary

MeasureTime frame
PULMONARY FUNCTIONTimepoint: PULMONARY FUNCTION (CLINICAL/ PFT) WILL BE ASSESSED AT BASELINE, POST RADIOTHERAPY, 3 MONTHS, 6 MONTHS, 9 MONTHS, 1 YEAR, 15 MONTHS, 18 MONTHS, 21 MONTHS AND 2 YEARS. LAST FOLLOW UP WILL BE AT THE END OF 2 YEARS.—

Countries

India

Contacts

Public ContactDr Jai Prakash Agarwal

Tata Memorial Hospital

jpthm@hotmail.com9867241770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026